| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $88.3M | +4.2% |
| Cost of Revenue | $24.8M | -1.1% |
| Gross Profit | $63.4M | +6.5% |
| R&D Expense | $21.2M | -2.2% |
| SG&A Expense | $27.4M | -4.3% |
| Operating Income | -$26.2M | +15.5% |
| Pre-tax Income | -$18.6M | +18.1% |
| Income Tax | $44K | +214.3% |
| Net Income | -$18.6M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $26.0M | -30.6% |
| Accounts Receivable | $490K | -23.8% |
| Current Assets | $111.9M | -24.4% |
| Total Assets | $145.8M | -19.4% |
| Current Liabilities | $28.5M | +2.7% |
| Total Liabilities | $46.5M | -0.2% |
| Stockholders' Equity | $99.3M | -26.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$2.9M | +78.5% |
| Capital Expenditures | $618K | +602.3% |
| Investing Cash Flow | $22.3M | +122.2% |
| Financing Cash Flow | -$30.7M | -746.1% |
| Free Cash Flow | -$3.5M | +74.1% |
| +17.9% |
| EPS (Basic) | -$0.49 | +14.0% |
| EPS (Diluted) | -$0.49 | +14.0% |